These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8880397)

  • 1. Folate, antifolates, and folate analogs in pediatric oncology.
    Hum MC; Kamen BA
    Invest New Drugs; 1996; 14(1):101-11. PubMed ID: 8880397
    [No Abstract]   [Full Text] [Related]  

  • 2. The antifolates.
    Visentin M; Zhao R; Goldman ID
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):629-48, ix. PubMed ID: 22520983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate and antifolate pharmacology.
    Kamen B
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-30-S18-39. PubMed ID: 9420019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies targeting proteins that regulate folate and reduced folate transport.
    Trippett TM; Bertino JR
    J Chemother; 1999 Feb; 11(1):3-10. PubMed ID: 10078775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
    Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
    Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Folate antagonist].
    Morikawa N
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():146-8. PubMed ID: 25831740
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate and Pralatrexate.
    Wood GS; Wu J
    Dermatol Clin; 2015 Oct; 33(4):747-55. PubMed ID: 26433846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The folate receptor as a potential therapeutic anticancer target.
    Gruner BA; Weitman SD
    Invest New Drugs; 1998-1999; 16(3):205-19. PubMed ID: 10360600
    [No Abstract]   [Full Text] [Related]  

  • 10. The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs.
    Goldman ID; Chattopadhyay S; Zhao R; Moran R
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1409-23. PubMed ID: 21154123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates.
    Backus HH; Pinedo HM; Wouters D; Padrón JM; Molders N; van Der Wilt CL; van Groeningen CJ; Jansen G; Peters GJ
    Int J Cancer; 2000 Sep; 87(6):771-8. PubMed ID: 10956384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate during antifolate chemotherapy: what we know... and do not know.
    Robien K
    Nutr Clin Pract; 2005 Aug; 20(4):411-22. PubMed ID: 16207681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
    Calvert H
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticancer antifolates: current status and future directions.
    McGuire JJ
    Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG
    Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Folate metabolism dysfunction].
    Righetti M
    G Ital Nefrol; 2008; 25(1):32-41. PubMed ID: 18264916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Methyltetrahydrohomofolate.
    O'Dwyer PJ; Wagner BH; Hoth DF; Leyland-Jones B
    Invest New Drugs; 1987; 5(3):215-8. PubMed ID: 3312079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets.
    Assaraf YG; Ifergan I; Kadry WN; Pinter RY
    J Theor Biol; 2006 Jun; 240(4):637-47. PubMed ID: 16352313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of one-carbon folate cycling related to fluoropyrimidine and antifolate therapy.
    Spears CP; Carlsson G; Muggia FM; Jaresko G; Gustavsson BG
    Cancer Treat Res; 1995; 78():115-34. PubMed ID: 8595140
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
    Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
    Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.